1. The Medicaid personal care services benefit: practices in states that offer the optional state plan benefit
« Previous |
1 - 100 of 504
|
Next »
Search Results
2. State profiles: reforming the health care system, 2005
3. Simplifying enrollment in Medicaid and Medicare savings programs for the elderly and individuals with disabilities
4. Staying the course: trends in family caregiving
5. An update on Chile's experience with partial privatization and individual accounts
6. Voluntary carve outs for Social Security reform: lessons from the United Kingdom
7. Training programs for certified nursing assistants
8. Rx watchdog report: trends in manufacturer prices of brand name prescription drugs used by Medicare beneficiaries 2002 to 2007
9. Workforce issues: views from 103 North Carolina employers : summary of findings from a web survey
10. Strategic analysis & intelligence (SAI) report: the tier 4 phenomenon : shifting the high cost of drugs to consumers
11. State-funded home and community-based services programs for older adults
12. Recognizing destabilization in the individual health insurance market
13. Weathering the storm: the impact of the Great Recession on long-term services and supports
14. Employers' use of health insurance exchanges: lessons from Massachusetts
15. Medicare's value-based, physician payment modifier: improving the quality and efficiency of medical care
16. The facts about prediabetes and older Americans
17. Solving Social Security: ensuring long-term stability
18. Social Security: a lifeline for older women and minorities
19. Breaking through the noise: the facts about the Medicaid program
20. Taking a closer look: myths about the Medicaid program and the people it helps
21. Closing the "doughnut hole" has helped protect millions of Medicare beneficiaries from high drug costs
22. Current issues in Social Security: financial capability and representative payees
23. Reducing potential overuse of dementia drugs could lead to considerable savings
24. Breaking new ground: supporting employed family caregivers with workplace leave policies
25. Supplemental benefits under Medicare Advantage. Part 1, An in-depth look at what they are today
26. Taking it to the next level: using innovative strategies to expand options for self-direction
27. State flexibility in a new era: what are the research priorities for Section 1115 demonstrations?
28. Medicaid and personal responsibility waivers: opportunities and challenges in evaluating potential impacts
29. California's ambulatory surgery centers: a black box of care
30. Short-term, limited-duration insurance and risks to California's insurance market
31. Leaning in to succeed in public hospitals
32. Eliminating the ACA's individual mandate: how would California fare?
33. Six facts about undocumented Californians: analysis of 2015--2016 California Health Interview Survey
34. California employer health benefits: workers shoulder more costs
35. Ensuring health plan mergers benefit the community: California regulators and infrastructure investment programs
36. California's uninsured: progress toward universal coverage
37. California emergency departments: use grows as coverage expands
38. Financing community health workers in transitions clinics
39. MAT in community health centers
40. Preventing unintended pregnancy in Mississippi
41. Health insurance coverage and the ACA: knowledge, attitudes, and behaviors of Mississippi adults
42. Mississippi Health Information Network (MS-HIN): moving from development to sustainability
43. Long-acting reversible contraceptives: a survey of Mississippi health care providers
44. Mississippi Medicaid tobacco-related cost
45. How could the public charge proposed rule affect community health centers?
46. Top spenders among commercially-insured: increased spending concentration and consistent turnover from 2013 to 2015
47. Under pressure: adults with hypertension are spending increasingly more on health care
48. The rising cost of specialty drugs drove spending increases for people with multiple sclerosis
49. Trends in primary care visits
50. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices
51. Why becoming a good parent begins in infancy: how relationship skills are developed throughout the life course
52. Aligning services with needs: characterizing the pyramid of complexity tiering for children with chronic and complex conditions
53. How California Children’s Services Programs in the 21 Whole-Child Model counties engage with families
54. A framework for assessing family engagement in systems change
55. Threading the labyrinth: why children in California with special health care needs endure delays in securing the medical equipment and supplies they need
56. A better way: team care for children with special health care needs
57. Achieving care integration for children with medical complexity: the human-centered design approach to care coordination
58. Five top tips for engaging families in advisory roles: advice from a family leader
59. The future of pediatrics: redefining chronic care
60. Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report
61. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report
62. Emicizumab for hemophilia A with inhibitors: effectiveness and value : final evidence report
63. Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary
64. Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report
65. Elagolix for treating endometriosis: final evidence report
66. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report
67. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report
68. Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report
69. Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report
70. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report
71. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report
72. Assessment and synthesis of selected Medicaid eligibility, enrollment, and renewal processes and systems in six states
73. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Arizona
74. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Colorado
75. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Florida
76. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Idaho
77. Medicaid eligibility, enrollment, and renewal processes and system study: case study summary report--New York
78. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--North Carolina
79. Leveraging 1332 state innovation waivers to stabilize individual health insurance markets: experiences of Alaska, Minnesota, and Oregon : final report : document efforts to stabilize the individual market using state-based reinsurance
80. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate
81. Low-wage workers: poverty and use of selected federal social safety net programs persist among working families : report to the ranking member, Subcommittee on Primary Health and Retirement Security, Committee on Health, Education, Labor, and Pensions, U.S. Senate
82. Climate change: information on potential economic effects could help guide federal efforts to reduce fiscal exposure : report to Congressional requesters
83. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate
84. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters
85. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives
86. Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives
87. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters
88. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives
89. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives
90. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress
91. Sunscreen: FDA reviewed applications for additional active ingredients and determined more data needed : report to Congressional committees
92. Food safety: FDA continues to evaluate and respond to business concerns about the produce rule : report to Congressional committees
93. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives
94. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives
95. Private school choice: federal actions needed to ensure parents are notified about changes in rights for students with disabilities : report to Congressional requesters
96. Veterans affairs contracting: improvements in buying medical and surgical supplies could yield cost savings and efficiency : report to the chairman, Committee on Veterans' Affairs, House of Representatives
97. Health insurance exchanges: changes in benchmark plans and premiums and effects of automatic re-enrollment on consumers' costs : report to Congressional requesters
98. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters
99. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees
100. Sexual violence: actions needed to improve DOD's efforts to address the continuum of unwanted sexual behaviors : report to the Committee on Armed Services, U.S. Senate
